| Bivariate | Adjusted | ||
---|---|---|---|---|
Characteristics | HR (95% CI) | p-value | aHR (95% CI) | p-value |
Intervention group | 1.0 (0.5;1.7) | 0.94 | Â | Â |
Male gender | 2.0 (0.1;4.0) | 0.05 | Â | Â |
Age <35Â years | 0.7 (0.4;1.4) | 0.37 | Â | Â |
Severe HIV (clinical stage 3 or 4) | 1.2 (0.6;2.1) | 0.59 | Â | Â |
History of IDU | 1.9 (1.0;3.3) | 0.04 | Â | Â |
ART-non-naïve status | 4.8 (2.4;9.4) | <0.01 | 7.0 (3.3–14.7) | <0.01 |
TB history | 1.6 (0.8;3.2) | 0.15 | Â | Â |
VL at baseline ≥100,000 copies/ml | 1.6 (0.9;2.8) | 0.13 | 2.3 (1.2–4.3) | <0.05 |
CD4 at baseline < 100 cells/μl | 1.4 (0.8;2.5) | 0.28 |  |  |
Having an HIV-infected family member | 0.5 (0.3;0.9) | 0.03 | Â | Â |
From Ha long OPC | 1.0 (0.6;1.8) | 0.91 | Â | Â |
History of OIs | 0.5 (0.2;1.0) | 0.06 | Â | Â |
Changed ART regimen | 1.1 (0.5;−2.0) | 0.85 |  |  |
Incomplete adherence | 2.4 (0.9;6.7) | 0.09 | 3.1 (1.1–8.9) | <0.05 |